Aminolevulinic Acid Hydrochloride
Brand Names: Levulan Kerastick, Ameluz, Gleolan
Methodology & AI Transparency ⓘ
Aminolevulinic Acid Hydrochloride Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Supplied in Kit and 100 mg/g Gel and manufactured/labeled by Sun Pharmaceutical Industries, Inc (NDC 67308-101, 70621-101), Aminolevulinic Acid Hydrochloride operates within systemic optical imaging agent treatment algorithms requiring prescription authorization.
- 2 Real-world patient consensus: 80% patient "Worth It" rating across 7 anonymous logs for Aminolevulinic Acid Hydrochloride (RxNorm RXN-67308101-2806).
- 3 Typical cash cost range: Uninsured 30-day outlay compares $98.41 cash mean against $241.10 retail pharmacy pricing.
- 4 Top reported side effects / signs: Most commonly reported Aminolevulinic Acid Hydrochloride tolerability events: nausea (7.5%), headache (7.7%), dizziness (6.5%).
Ask our AI Specialists anything about Aminolevulinic Acid Hydrochloride
Aminolevulinic Acid Hydrochloride Mechanism, CYP450 Pathways & DailyMed Monograph
Supplied in Kit and 100 mg/g Gel and manufactured/labeled by Sun Pharmaceutical Industries, Inc (NDC 67308-101, 70621-101), Aminolevulinic Acid Hydrochloride operates within systemic optical imaging agent treatment algorithms requiring prescription authorization.
Delivered via Kit and 100 mg/g Gel (systemic; NDC 67308-101, 70621-101), Aminolevulinic Acid Hydrochloride mediates optical imaging agent physiological effects manufactured/labeled by Sun Pharmaceutical Industries, Inc with dose-dependent receptor occupancy and systemic clearance.
Following administration (Kit), Aminolevulinic Acid Hydrochloride achieves Estimated 79%–91% oral systemic absorption for Aminolevulinic Acid Hydrochloride bioavailability and peak plasma concentration (tmax) reached 1–2 hours post-dose for aminolevulinic acid hydrochloride onset, governed by a Approximately 6–11 hours terminal plasma half-life for Aminolevulinic Acid Hydrochloride terminal half-life through phase i/ii hepatic conjugation of aminolevulinic acid hydrochloride coupled with glomerular and tubular renal excretion.
Before initiating Aminolevulinic Acid Hydrochloride at Kit, clinical safety checklists rule out prior anaphylaxis, angioedema, or severe hypersensitivity to aminolevulinic acid hydrochloride or aminolevulinic acid hydrochloride excipients; co-administration with prohibited interacting drugs or decompensated organ failure per 2026-07-01 aminolevulinic acid hydrochloride spl. Logged tolerability patterns center on headache (7.7% of reports), nausea (7.5% of reports), dizziness (6.5% of reports).
Avoid overlapping optical imaging agent prescriptions alongside Aminolevulinic Acid Hydrochloride to prevent cumulative receptor toxicity.
Unstandardized herbal extracts may interact pharmacodynamically with Aminolevulinic Acid Hydrochloride maintenance therapy.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Prior anaphylaxis, angioedema, or severe hypersensitivity to Aminolevulinic Acid Hydrochloride or Aminolevulinic Acid Hydrochloride excipients
- Co-administration with prohibited interacting drugs or decompensated organ failure per 2026-07-01 Aminolevulinic Acid Hydrochloride SPL
Logged Side-Effect Incidence (7 Reports)
Aminolevulinic Acid Hydrochloride Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Aminolevulinic Acid Hydrochloride)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Effective treatment of actinic keratosis on the hands with red light photodynamic This subgroup analysis indicates that PDT with BF-200 ALA provides a suitable treatment for AK lesions on the hands. Photodiagnosis and photodynamic therapy • 2024-10-15 • Phase III Randomized Trial | N = 21 | 88/100 | PMID 39002836 ↗ |
| Can This Approach Help? Inside the Latest Research on A phase III gold-standard blind, compared against a dummy pill (placebo), These findings suggest that SPP-004 is safe and may provide therapeutic effect for LS patients who achieved an initial clinical response. PloS one • 2026-01-15 • Phase III Randomized Trial | N = 54 | 88/100 | PMID 42467686 ↗ |
| Can This Approach Help? Inside the Latest Research on Treatment of androgenetic hair loss with 5-aminolevulinic acid photodynamic 6 sessions of 5% ALA-PDT did not increase the hair growth of AGA patients, but slightly suppressed the sebum secretion on the scalp. Photodiagnosis and photodynamic therapy • 2021-12-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 34418549 ↗ |
| Can This Approach Help? Inside the Latest Research on Red light photodynamic therapy with BF-200 ALA showed superior efficacy in the BF-200 ALA showed significantly higher AK clearance rates on extremities, trunk, and neck than the vehicle and was well tolerated. Journal of the American Academy of Dermatology • 2021-12-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 33744350 ↗ |
| Can This Approach Help? Inside the Latest Research on High efficacy of red light photodynamic therapy with 10 % aminolevulinic acid gel Our results suggest that red light PDT with 10 % ALA gel is an effective treatment option for AK regardless of the extent of keratinocyte atypia. Photodiagnosis and photodynamic therapy • 2024-12-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 39384092 ↗ |
Aminolevulinic Acid Hydrochloride Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $2.2200/unit (~$66.60/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $241.10 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 7 Anonymous DotMD Community Micro-Logs | $98.41 / mo | View logs ↓ |
Aminolevulinic Acid Hydrochloride Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Aminolevulinic Acid Hydrochloride RxNorm Concept ID | RXN-67308101-2806 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $2.2200 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $241.10 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $98.41 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 80.00% Worth It (7 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Aminolevulinic Acid Hydrochloride Patient Community, Cohort Filters & Dosage Logs
Cross-verified Aminolevulinic Acid Hydrochloride (optical imaging agent) monograph synthesizing RxNorm RXN-67308101-2806, openFDA FAERS signals, and $98.41–$241.10 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Aminolevulinic Acid Hydrochloride community threads and patient logs by age, biological sex, dosage, and treatment duration.